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KESAN PENGGANTIAN MAGNESIUM-SILIKON  
TERHADAP CIRI-CIRI HIDROKSIAPATIT KARBONAT TULANG 
SINTETIK 
 
ABSTRAK 
 
Serbuk magnesium-silikon hidroksiapatit terkarbonat bersaiz nano jenis B 
(Mg-Si CHA) di perolehi dengan kaedah pengemulsian nano melalui teknik tuangan 
langsung (DP) pada suhu ambien. Magnesium (Mg) dan silicon (Si) ditukar ganti ke 
dalam struktur kekisi hidroksiapatit karbonat supaya ia lebih menyamai komposisi 
kimia tulang semulajadi manusia. Partikel Mg-Si CHA menunjukkan bentuk sudut 
atau hampir bulat dengan dimensi 10-40 nm (panjang) dan 5-20 nm (lebar). 
Penggabungan Mg dan Si kurang dari 1% ke dalam kekisi CHA menunjukkan tiada 
kesan terus terhadap komposisi fasa, yang terbukti dari hasil keputusan Belauan 
sinar-X (XRD) dan Spektroskop infra merah jelmaan Fourier (FTIR). Persinteran 
kemudiannya dijalankan ke atas sampel Mg-Si CHA pada suhu 800°C dan dibiarkan 
selama 2 jam. Dalam peringkat penyejukkan, sampel yang telah disinter dikeluarkan 
dari relau bila suhu mencecah 200°C dan diletakkan dalam desikator. Gas CO2 basah 
dipamkan ke dalam desikator untuk menggantikan karbonat yang terurai daripada 
sampel semasa persinteran. Kandungan karbonat Mg-Si CHA tersinter adalah 6.80%, 
iaitu jatuh dalam julat tipikal untuk tulang semulajadi. Kebioaktifan in vitro 
magnesium-silikon tertukar ganti hidroksiapatit karbonat (Mg-Si CHA) telah dinilai 
melalui rendaman sampel dalam larutan badan simulasi (SBF) sebagai medium dan 
ujian ketoksidan dalam erti kata tindakbalas sel kultur. Keputusan ujian 
menunjukkan Mg-Si CHA tersinter mempunyai kebolehan membentuk apatit dengan 
lebih cepat dan tidak toksik terhadap fibroblas manusia, seperti yang 
xviii 
 
didemonstrasikan oleh bilangan sel berdaya hidup yang tinggi. Kesimpulannya, Mg-
Si CHA berkemungkinan boleh digunakan sebagai bahan pengganti tulang.       
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EFFECT OF MAGNESIUM-SILICON SUBSTITUTION ON THE 
CHARACTERISTICS OF CARBONATED HYDROXYAPATITE FOR 
SYNTHETIC BONE 
 
ABSTRACT 
 
The nano-sized B-type magnesium-silicon carbonated hydroxyapatite (Mg-Si 
CHA) powders was successfully synthesized by nanoemulsion method through direct 
pouring (DP) technique at ambient temperature. Magnesium (Mg) and silicon (Si) 
were substituted into the carbonated hydroxyapatite (CHA) lattice structure in order 
to mimic the chemical composition of the human natural bone. The Mg-Si CHA 
particles exhibit angular or near spherical-like in shape with the dimension of 10-40 
nm (length) and 5-20 nm (width). The incorporation of less than 1% of Mg and Si 
into the CHA lattice appears to have no direct effect on the phase composition, as 
evidenced by X-ray Diffraction (XRD) and Fourier Transform Infrared Spectroscopy 
(FTIR) results. Sintering was then performed on the Mg-Si CHA sample at 800°C 
and 2 hours soaking. During the cooling stage, the sintered sample was taken out 
from the furnace when the temperature reaches 200°C and placed in a desiccators. 
Wet carbon dioxide gas (CO2) was pumped into the desiccators to compensate the 
carbonate loss during sintering. The carbonate content of sintered Mg-Si CHA was 
6.80%, which is fall in the range typically reported for natural bone (3 to 8%). In 
vitro bioactivity of the Mg-Si CHA was evaluated through immersion sample in 
simulated body fluid (SBF) solution as a medium and cytotoxicity test in term of cell 
culture response. The results revealed that the Mg-Si CHA had good bioactivity by 
rapid apatite formation ability and found to be non-cytotoxic on the human 
fibroblast, as demonstrated by high cell viabilities. In conclusion, Mg-Si CHA may 
be used as a synthetic bone substitution material. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1 Research Backgrounds 
Surgical procedures are typically performed to replace, repair or regenerate 
bone defects, that are caused by numerous diseases, genetic abnormalities and 
traumatic injuries (Ana et al., 2010). These are commonly done in the field of 
orthopaedics, neurosurgery and dentistry. Conventionally, bone grafts adopted from 
the patient‟s own body (autograft) or from another person (allograft) or even from 
animal‟s tissue (xenograft) have been used to heal or to fill such bone defects. 
Nevertheless, the availability of autografts is limited, while harvest is expensive, 
painful and associated with donor-site morbidity due to infection and hematoma. On 
the other hand, allograft and xenograft procedures risked of transmitting disease from 
donor to patient or possible rejection by the patient‟s immune system (O‟Brien, 
2011). These shortcomings, including multiple operating procedures, have motivated 
and driven for synthetic bone grafts. 
Bone is a complex living tissue with various levels of hierarchical structural 
units from macro to nano scales, to meet multiple functions (Murugan & 
Ramakrishna, 2005). It is a vascular dynamic tissue that has a unique capability of 
self-remodelling or self-regenerating throughout the lifetime of an individual. 
Typically, the bones assist in locomotion activity, while ensuring the skeleton has 
adequate load-bearing capacity, and acts as a protective casing for the delicate 
internal organs of the body as reported by Stevens (2008). Bones also serves a 
reservoir for the storage of essential minerals, particularly calcium and phosphate 
(Murugan & Ramakrishna, 2005). Although bone is considered the strongest tissue in 
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the body, it is easy to fracture resulting from injury and degenerative diseases 
associated with ageing. The most frequent occurring fractures are hip, ankle, tibia 
and fibula fractures. The number of hip fractures are more than 280,000 every year in 
the United States and incidence is expected to double by 2050 (Isnoni et al., 2012). 
In the UK, hip fracture incidence will rise from 70,000 per year in 2006 to 101,000 in 
2020 as reported by Departmental of Health Hospital (England). Moreover, Hernlund 
et al. (2013) had reported that the annual number of fractures in the European Union 
(EU) will rise from 3.5 million in 2010 to 4.5 million in 2025, corresponding to an 
increase of 28%. Many reports have shown an increase in the incidence of hip 
fractures in Asian population. There was 1.66 billion cases of hip fracture reported in 
1990 and it is estimated to increase to 6.26 billion in 2050 due to the growth of the 
elderly population as reported by Aseel Hadi Abdulameer et al. (2017). As the 
longevity increased, older people (above 50 years old) are 10-15 times easily to 
fracture a hip than those younger. In Malaysia, there was 10 per 100,000 for the 
range of 50-54 years old, and rising to 510 per 100,000 in those over 75 years old 
(Yeap et al., 2016). According to ethnic background, Chinese and Malays have 
higher rates of hip fracture as compared to Indian (Aseel Hadi Abdulameer et al., 
2017).   
Injuries due to road mishaps also contribute to high demands of bone grafting 
procedure. Malaysia had a high number of road accidents, with the total number of 
accident reported at 489,606 cases in 2015, which was an increase from 476,196 in 
2014, corresponding to an increase of 2.8% (Malaysia Transport Statistics 2015). 
This reflects orthopaedic injuries was high among Malaysian road users. As a result, 
bone grafting procedures become one of the important surgeries performed at 
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hospitals. Therefore, there is a great need to develop synthetic alternative 
biomaterials for bone replacement, repair and augmentation (LeGeros, 2008).  
Various kinds of biomaterials have been developed and used as bone graft 
substitutes (BGS) such as ceramics, metals, polymers and their composites. Among 
the ceramic materials, hydroxyapatite (HA) has been used widely as bone graft 
substitute due to its biocompatibility, bioactivity, osteoconductivity, non-toxicity and 
non-inflammatory properties (Malina et al., 2013). Moreover, the chemical and phase 
composition of HA also mimics the mineral phase of natural bone (Cacciotti, 2016). 
Although synthetic HA has the ability to allow new bone to form along its surface, 
the usage of synthetic HA in medical applications is limited, because of its slow rate 
of osseointegration, remodelling in the body over a long period of time, as well as a 
relatively low fracture strength and toughness (Gibson et al., 2002). Synthetic HA 
also does not degrade significantly but rather remains as a nearly permanent fixture 
susceptible to long term failure (Ishikawa et al., 2003).  
One way to enhance the bioactive behaviour of HA is to develop substituted 
apatites, resembling the chemical composition and structure of the mineral phases in 
human bones. These ionic substitution can modify the surface structure and electrical 
charge of HA, leading to major changes in biological performance upon implantation 
(Supova, 2015).Carbonate ion is the most abundant substitutions and has been 
reported to be about 3-8 wt%, depending on the age of the individual (Barinov et al., 
2006). In this sense, the biological apatite is regarded as carbonated hydroxyapatite 
(CHA), with a variety of other ions substituted in its lattice such as sodium, 
magnesium and strontium. Recently, Sr, Mg, Zn, Mn, Li, Cu, F and Si ions have 
attracted much interest because of the positive effects on bone repair and 
regeneration (Xia, 2013). Sr ion has been shown to stimulate osteoblast activity, bone 
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strength and bone growth. Li ion could enhance the proliferation and cementogenic 
differentiation of human periodontal ligament-derived cells (Han et al., 2012). 
Similarly, Zn ion inhibitsbone resorption, supports bone growth, enhances 
antimicrobial resistance, as well as increases the activity of osteoblasts, thus resulting 
in increased bone formation (Gopi et al., 2015). Si substitution has been proven to 
enhance the apatite solubility, thus increase the bioactivity (Tampieri et al., 2016), 
whereas Mg plays an important role in bone metabolism stimulating osteoblast cell 
proliferation (Lala et al., 2016). 
1.2 Problem Statement 
 Substituted hydroxyapatites have significant advantages in terms of 
biodegradability and bioactivity compared to the stoichiometric hydroxyapatite, as 
reported by Supova (2015). Currently, CHA is accepted as a prospective material in 
medical applications in order to mimic the composition of natural bone                          
(Roveri & Iafisco, 2010). The co-substitution of carbonate with silicate, strontium or 
magnesium has been shown to ensure controlled release and improved biological 
response in vitro (Landi et al., 2010; Sprio et al., 2008). Co-substitutions have also 
been carried out in order to counteract the structural changes that occur during 
substitution and prevent destabilization of the structure and subsequent 
decomposition during heat treatment. These include the co-substitution of carbonate 
with magnesium (Abdelkader et al., 2014) or yttrium with silicon (Stephen et al., 
2007). However, there is lacking of research on the co-substitution of multiple (more 
than two) ions in HA crystal structure which would accurately mirror the chemistry 
of the natural bone, in order to produce the most effective bone substitute materials. 
As such, this research embarks on the study of co-substitution of HA with carbonate, 
Si and Mg. The limited thermal stability of the CHA is also a challenge, as poor 
